Innovation for better health
Instacare aims to convert the findings from basic science into meaningful therapeutic options with the ultimate goal to improve public health efficiently, quickly and economically. Successful implementation of early clinical and translational research has proven to be an effective strategy, with successful proof-of-concept studies being the benchmark of success. Advancements in biotechnology and artificial intelligence have created vast opportunities for developing new ways to prevent, diagnose, and treat human diseases.
The epidemic of obesity is now recognized as one of the most important public health problems facing the world today. Instacare therapeutics uses innovation in genetics, molecular biology, and artificial intelligence to develop new therapies to fight metabolic diseases. Our R & D has identified a gene crucial for the development of metabolic diseases, and very recently has developed compounds to prevent development of Fatty liver diseases. The challenge now is to translate benchside experimental data to the clinic.